Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Fleischmann
Cost-Effectiveness of Hepatitis C Virus (HCV) Treatment With Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy Versus Waiting for New Regimens in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Human Immunodeficiency Virus Causes Mononuclear Phagocyte Dysfunction.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Combination Therapy With Pegylated Interferon Plus Ribavirin in the Treatment of Hepatitis C Virus-Related Thrombocytopenia
Current Therapeutic Research
Pharmacology
Mixed Treatment Comparisons to Compare Simeprevir With Boceprevir and Telaprevir in Combination With Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected With Genotype 1 Hepatitis C Virus (Hcv)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Associated With Thyroid Dysfunction
Acta Hepatologica Japonica
Hepatology
Hepatitis C Virus Core Protein Substitutions Affect the Response to Pegylated-Interferon and Ribavirin Therapy
BMC Genomics
Biotechnology
Genetics
Non-Invasive Fibrosis Assessment Predicts Sustained Virological Response to Telaprevir With Pegylated Interferon and Ribavirin for Chronic Hepatitis C
Antiviral Therapy
Infectious Diseases
Pharmacology
Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients
PLoS ONE
Multidisciplinary
Acute Pancreatitis Associated With Pegylated Interferon-Alpha-2a Therapy in Chronic Hepatitis C
Clinical and molecular hepatology
Medicine
Hepatology
Molecular Biology
Cost Effectiveness of Interferon or Peginterferon With Ribavirin for Histologically Mild Chronic Hepatitis C
Gut
Gastroenterology
Prediction of Anemia in Triple Therapy With Peginterferon ^|^alpha;-2b, Ribavirin, and Telaprevir for Patients With Chronic Hepatitis C From the Viewpoint of Renal Function
Acta Hepatologica Japonica
Hepatology
